AstraZeneca PLC (AZN)
65.04
-0.25
(-0.38%)
USD |
NASDAQ |
Nov 14, 16:00
63.83
-1.21
(-1.86%)
After-Hours: 04:44
AstraZeneca Cash and Short Term Investments (Quarterly): 7.076B for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.076B |
| March 31, 2024 | 8.021B |
| December 31, 2023 | 5.86B |
| September 30, 2023 | 5.115B |
| June 30, 2023 | 5.812B |
| March 31, 2023 | 6.462B |
| December 31, 2022 | 6.243B |
| September 30, 2022 | 4.898B |
| June 30, 2022 | 4.887B |
| March 31, 2022 | 5.823B |
| December 31, 2021 | 6.398B |
| September 30, 2021 | 7.149B |
| June 30, 2021 | 15.63B |
| March 31, 2021 | 7.765B |
| December 31, 2020 | 7.992B |
| September 30, 2020 | 8.446B |
| June 30, 2020 | 6.115B |
| March 31, 2020 | 4.165B |
| December 31, 2019 | 6.217B |
| September 30, 2019 | 4.78B |
| June 30, 2019 | 6.247B |
| March 31, 2019 | 4.958B |
| December 31, 2018 | 5.594B |
| September 30, 2018 | 4.228B |
| June 30, 2018 | 3.777B |
| Date | Value |
|---|---|
| March 31, 2018 | 3.871B |
| December 31, 2017 | 4.554B |
| September 30, 2017 | 5.211B |
| June 30, 2017 | 6.237B |
| March 31, 2017 | 3.659B |
| December 31, 2016 | 5.811B |
| September 30, 2016 | 3.999B |
| June 30, 2016 | 4.646B |
| March 31, 2016 | 4.099B |
| December 31, 2015 | 6.743B |
| September 30, 2015 | 4.577B |
| June 30, 2015 | 4.498B |
| March 31, 2015 | 3.685B |
| December 31, 2014 | 7.041B |
| September 30, 2014 | 5.95B |
| June 30, 2014 | 5.777B |
| March 31, 2014 | 5.156B |
| December 31, 2013 | 9.894B |
| September 30, 2013 | 8.317B |
| June 30, 2013 | 9.091B |
| March 31, 2013 | 8.029B |
| December 31, 2012 | 8.223B |
| September 30, 2012 | 6.816B |
| June 30, 2012 | 9.196B |
| March 31, 2012 | 9.969B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.165B
Minimum
Mar 2020
15.63B
Maximum
Jun 2021
6.846B
Average
6.243B
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| GSK PLC | 4.298B |
| Amgen Inc | 9.011B |
| Johnson & Johnson | 20.30B |
| Eli Lilly and Co | 3.518B |
| Sanofi SA | -- |